Before Infant Formula Recall, Abbott ‘Closed-Done’ With Investigation Complaint Referencing Death
Agency Officials' Report Critical Of Abbott's Complaint Investigation Procedures
Executive Summary
FDA report on inspection states Abbott and agency “found evidence" of Cronobacter species bacteria in powdered infant formula production environment and firm also identified bacteria in finished powdered formula products. Once Abbott gets FDA clearance to restart production at facility, it will need as much as two months before formula made there reaches stores.
You may also be interested in...
Abbott Speaks Lingo Wearables For Future Growth, Posts Formula As Current Consumer Sales Driver
Lingo’s target “is to do something that not a lot of well-established health care companies do, which is to create a product that's really targeting a healthy population and a healthy population that wants to stay healthy,” says CEO Robert Ford.
Infant Formula Shipped From Texas Strip Mall Without Sufficient Bacteria Testing
FDA says Mother’s Touch Formula made available without pre-market notification and with essential nutrients below required levels. Marketer’s address is a strip mall with fast food restaurants, hair salon, postal services business, grocery store and congressional candidate’s campaign office.
Abbott Hoists Forecast Sails Higher Despite Infant Formula, Inflation, Exchange Headwinds
Although sales of infant formula and other pediatric nutritionals were down more than 20% in US and more than 13% worldwide during Q2 on an organic measure – excluding a currency exchange impact – Abbott reports 14.3% overall sales growth to $11.3bn.